- Screen everyone with alcohol use: PAWSS ≥4 = high risk of complicated withdrawal.
- Symptom-triggered benzodiazepines (CIWA-Ar ≥8–10) for most. CIWA needs a patient who can talk.
- Severe / resistant / DTs → phenobarbital (or escalating benzos) → ICU.
- Thiamine before glucose. Wernicke risk → thiamine 200–500 mg IV TID.
- Start AUD treatment before discharge (naltrexone, acamprosate, gabapentin) + linkage.
Pathophysiology in 60 seconds
⌄
- Chronic alcohol boosts GABA-A and blocks NMDA. The brain adapts: fewer GABA receptors, more NMDA receptors.
- Stop alcohol → too little inhibition, too much excitation → tremor, sympathetic surge, seizures, delirium.
- Each withdrawal episode makes the next one worse (kindling).
- Benzodiazepines and phenobarbital replace the missing GABA effect; phenobarbital also blocks glutamate.
Timeline
⌄
| Hours after last drink | Syndrome |
|---|---|
| 6–24 h | Minor withdrawal: tremor, anxiety, sweats, tachycardia, insomnia |
| 12–48 h | Withdrawal seizures (generalized, brief) |
| 12–48 h | Alcoholic hallucinosis (clear sensorium) |
| 48–96 h | Delirium tremens: confusion, autonomic instability, fever — mortality 1–5% treated |
| PAWSS items (examples) |
|---|
| Prior withdrawal, prior seizures/DTs, prior alcohol rehab, blackouts, combined with downers, other drug use, BAC >200 on arrival, autonomic hyperactivity (HR >120, tremor, sweats) |
Rule out: hypoglycemia, infection (meningitis, pneumonia), head injury (subdural!), hepatic encephalopathy, other drug withdrawal/toxicity.
Management
⌄
- Symptom-triggered (CIWA ≥8–10): lorazepam 1–4 mg (liver disease, elderly) or chlordiazepoxide 25–100 mg / diazepam 10–20 mg (long-acting, smoother).
- Front-loading diazepam 10–20 mg IV q5–10 min for severe agitation.
- Escalating doses without response → benzodiazepine-resistant → phenobarbital, ICU.
- Single load 10 mg/kg IV (ideal body weight) over 30 min (some protocols 10–15 mg/kg) — self-tapers (long half-life).
- Or as add-on 130–260 mg IV boluses.
- Watch sedation and breathing, especially combined with benzos.
- Thiamine: 100 mg daily if low risk; 200–500 mg IV TID × 3–5 days if Wernicke suspected (confusion, ataxia, ophthalmoplegia — often only one sign).
- Folate, multivitamin. Replete K, Mg, Phos (refeeding).
- Avoid antipsychotics alone (lower seizure threshold) — only as adjunct for hallucinations.
- Dexmedetomidine: adjunct for autonomic signs, does not prevent seizures.
| Drug | Note |
|---|---|
| Naltrexone 50 mg daily / 380 mg IM monthly | Not with opioids or acute hepatitis/liver failure |
| Acamprosate 666 mg TID | Safe in liver disease; dose-reduce CrCl 30–50, avoid <30 |
| Gabapentin 300–600 mg TID | Also helps mild withdrawal/insomnia |
| Baclofen | Option in cirrhosis |
| Topiramate | Off-label |
Pitfalls
⌄
- CIWA scoring in a delirious, intubated or non-verbal patient.
- Giving glucose before thiamine.
- Missing a subdural hematoma or meningitis as the cause of "DTs."
- Discharging without AUD medication or follow-up.
Board corner
⌄
| Stem | Answer |
|---|---|
| Day 3 after admission: fever, tachycardia, confusion, hallucinations | Delirium tremens |
| Hallucinations, oriented, normal vitals, 24 h after last drink | Alcoholic hallucinosis |
| Confusion, ataxia, nystagmus | Wernicke → high-dose IV thiamine |
| Withdrawal + cirrhosis — which benzo? | Lorazepam (or oxazepam) |
| AUD + cirrhosis — which relapse drug? | Acamprosate or baclofen |
References
⌄
- ASAM Clinical Practice Guideline on Alcohol Withdrawal Management. J Addict Med. 2020;14(3S Suppl 1):1.
- Maldonado JR, et al. PAWSS. Alcohol Alcohol. 2014;49:477.
- Rosenson J, et al. Phenobarbital for acute alcohol withdrawal: a prospective RCT. J Emerg Med. 2013;44:592.